Connect Biopharma Holdings Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Barry Quart
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | less than a year |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 2yrs |
| Promedio de permanencia en la Junta Directiva | 3.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Connect Biopharma Holdings (NASDAQ:CNTB) Is In A Strong Position To Grow Its Business
Sep 27
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth
Mar 07Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?
Sep 19Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?
Mar 29Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?
Dec 14Market Appears To Relegate Connect Biopharma To A Long-Term Hold
Oct 10Connect Biopharma Is A Sleeper Heading Into October Data Readout
Sep 26Connect Biopharma reports 1H results
Sep 13We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate
Aug 12We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate
Apr 29Connect Biopharma's Latest Dermatitis Drug Update Fails To Pump Up Shares
Jan 12We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely
Jan 01CEO
Barry Quart (67 yo)
less than a year
Permanencia
Dr. Barry D. Quart, Pharm D., serves as Chief Executive Officer & Director of Connect Biopharma Holdings Limited since June 12, 2024. He had served as Chief Executive Officer of Heron Therapeutics, Inc. si...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder & Director | 12.8yrs | sin datos | 10.73% $ 6.2m | |
| Co-Founder & Director | no data | sin datos | 11.22% $ 6.5m | |
| CEO & Director | less than a year | sin datos | sin datos | |
| President | less than a year | sin datos | sin datos | |
| General Counsel & Chief Compliance Officer | 3.3yrs | sin datos | sin datos | |
| VP of Biologics & Head of CMC | 4.8yrs | sin datos | sin datos | |
| VP & Global Head of Medical Affairs | no data | sin datos | sin datos | |
| Senior Vice President of Clinical Development(Consultant) | less than a year | sin datos | sin datos |
2.0yrs
Permanencia media
60yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CNTB se considera experimentado (2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder & Director | 12.8yrs | sin datos | 10.73% $ 6.2m | |
| Co-Founder & Director | 12.5yrs | sin datos | 11.22% $ 6.5m | |
| CEO & Director | less than a year | sin datos | sin datos | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos | |
| Independent Director | 3.3yrs | sin datos | 0% $ 0 | |
| Independent Non-Executive Director | 3.9yrs | sin datos | 0.018% $ 10.5k | |
| Independent Chairman | 3.9yrs | sin datos | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 3.9yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos |
3.8yrs
Permanencia media
60.5yo
Promedio de edad
Junta con experiencia: La junta directiva de CNTB se considera experimentada (3.8 años de antigüedad promedio).